Biosolution Bayview News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of...

The first batch of the Pfizer vaccine (325,260 doses) was expected to land at OR Tambo International Airport on Sunday, 2 May, just before midnight, the Minister of Health, Dr Zweli Mkhize, announced. He said a safety plan for the vaccines had been designed by the National Joint Operational and Intelligence Structure (NatJoints), and all security agencies would be engaged to ensure that the necessary security procedures were in place for safe delivery of the vaccine. “Upon arrival the entire batch will be transported initially to a central warehouse. Samples will be sent to the National Con...

Feds Halt Production at Emergent BioSolution's COVID-19 Vaccine Plant in Baltimore Industry Segment: Pharmaceutical & Biotech | Word Count: 124 Words SUGAR LAND--April 23, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Armed with a list of manufacturing violations, the Food and Drug Administration (FDA) has halted production at contract manufacturer (CMO) Emergent BioSolution's Bayview plant in Baltimore, Maryland. In addition, 60 million doses of the Johnson & Johnson (NYSE:JNJ) "one-shot" COVID-19 vaccines have been quarantined, meaning the bulk drug product will not b...

So what Emergent BioSolutions continues to reel from manufacturing issues at its Bayview facility that caused 15 million doses of Johnson & Johnson's COVID-19 vaccine to be discarded. The New York Times reported in late March that the company's staff had inadvertently contaminated a batch of J&J's vaccine with ingredients from AstraZeneca's COVID-19 vaccine.  Image source: Getty Images. That highly publicized glitch led Johnson & Johnson to step in and temporarily manage the production of its vaccine at Emergent BioSolutions' Bayview facility. However, today's news means that J&J's efforts ...